Alzheimer’s
-
Drug discovery efforts continue in latest chemical chronicle from the Warren Center for Neuroscience Drug Discovery
Led by Craig W. Lindsley, Vanderbilt drug discovery experts set out to develop a backup drug candidate to improve memory loss in people with Alzheimer’s disease. Read MoreOct 31, 2024
-
Basic science research featured at 2024 Vanderbilt Alzheimer’s Disease Research Day
The Vanderbilt Memory and Alzheimer's Center hosted its fifth Annual Vanderbilt Alzheimer’s Disease Research Day on April 10 with the theme of “big data.” Aside from presentations from faculty from across campus and the School of Medicine Basic Sciences, the day featured data blitzes, a keynote presentation, and a poster reception with more than 45 posters. Read MoreApr 24, 2024
-
Lippmann wins prestigious Chan Zuckerberg Initiative award to back research in the fight against Alzheimer’s
Ethan Lippmann, associate professor of chemical and biomolecular engineering and biomedical engineering, has won a Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative (CZI) to create a more effective way for the immune system to fight against neurodegenerative diseases like Alzheimer’s. Read MoreFeb 28, 2024
-
Vanderbilt researcher wins grant to study risk factors for Alzheimer’s disease, dementia in older LGBTQ+ adults; experts present at Alzheimer’s conference
Experts in research on Alzheimer’s disease and related dementias share their latest findings at the 2023 Alzheimer’s Association International Conference. Nik Lampe, postdoctoral researcher, was awarded a grant to examine the social and medical factors influencing ADRD using data from VUSNAPS. Read MoreAug 31, 2023
-
Novel research could provide better analysis of EVPs’ roles in diseases, cancer
Vanderbilt engineering professor Justus Ndukaife is leading innovative research that more effectively traps nanosized extracellular vesicles and particles to analyze their roles in cancer, and neurodegenerative diseases. Read MoreAug 14, 2023
-
Protein tag determines trafficking of cargo to different cellular compartments
SNARE proteins determine how tiny membrane pouches called vesicles fuse with different cellular compartments to transport cargo and organize cells. How cells correctly target individual SNAREs to their destination is poorly understood, but the laboratories of Todd Graham, Jason MacGurn and Lauren Jackson recently published a paper uncovering part of the process that controls this compartmentalization. Read MoreDec 16, 2022
-
Study measures Alzheimer’s risk reductions associated with healthy lifestyles
Reported June 13 in Neurology, an Alzheimer’s disease risk study from Vanderbilt University Medical Center measures significantly reduced risk associated with healthy lifestyles, including non-smoking, leisure-time exercise, low-to-moderate alcohol consumption, adequate sleep and healthy diet. Read MoreJun 13, 2022
-
Kalousová, Bolton receive Alzheimer’s Association awards
Lucie Kalousová, assistant professor of medicine, health and society and of sociology, has received a two-year New to the Field Award of $114,000 from the Alzheimer’s Association. Corey Bolton, a postdoctoral fellow at the Vanderbilt Memory and Alzheimer’s Center, has been awarded a two-year, $140,000 Alzheimer’s Association Clinician Scientist Fellowship. Read MoreApr 21, 2022
-
Study seeks African American adults Feb. 23 for Alzheimer’s disease storytelling research
Vanderbilt University’s RASR Laboratory in the Department of Chemistry is seeking African American individuals, age 40 and older, who reside in Nashville and the surrounding communities to participate in a one-time, two-hour focus group on Wednesday, Feb. 23, from 6 to 8 p.m. to review short videos and materials and provide feedback. Read MoreSep 16, 2021
-
Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize
Behavioral and systems neuropharmacologist Jerri Rook is recognized by the Alzheimer’s Drug Discovery Foundation with the Goodes Prize to continue her work in Alzheimer’s disease research. Read MoreNov 2, 2020
-
How proteins spread linked to Alzheimer’s disease sex differences
The ways certain proteins spread may help explain why the prevalence of Alzheimer’s is higher in women than in men. Read MoreJul 18, 2019
-
Free memory and Alzheimer’s gene screenings May 14
Staff from the Center for Cognitive Medicine will administer memory screenings and Alzheimer’s gene screenings at no cost to community members ages 60 and above. Read MoreMay 10, 2019
-
Center for Cognitive Medicine offering Alzheimer’s APOE4 Gene Screening
Center for Cognitive Medicine offering Alzheimer's APOE4 Gene Screening at Whole Foods on Feb. 18. Read MoreFeb 12, 2019
-
Volunteers needed for study exploring Alzheimer’s risk
The Center for Cognitive Medicine is seeking volunteers ages 65-75 who have not been diagnosed with any memory impairment and are interested in whether their genetics show they are at increased risk of Alzheimer’s disease. Read MoreJan 4, 2019
-
Center for Cognitive Medicine open house and Alzheimer’s screening
Interested in the treatments and prevention of Alzheimer's disease? The Center for Cognitive Medicine is hosting an open house and screening event on Sept. 7. Read MoreSep 4, 2018
-
Enzyme helps build motor that drives neuron death
The process, discovered in the axons of neurons, is implicated in Alzheimer’s, amyotrophic lateral sclerosis, traumatic brain injury and other diseases or injuries to the nervous system. Read MoreAug 6, 2018
-
ApoE4 Alzheimer’s Gene Screening on Aug. 3
The Center for Cognitive Medicine at Vanderbilt University Medical Center in partnership with the Generation Program will be offering ApoE4 Alzheimer’s Gene Screening on Friday, August 3. Read MoreAug 1, 2018
-
BOLD view of white matter
Vanderbilt investigators have discovered that functional MRI detects neural activity in both gray and white matter in the brain, suggesting new ways to investigate diseases such as Alzheimer’s and multiple sclerosis. Read MoreJan 12, 2018
-
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects. Read MoreAug 7, 2017
-
Learn about communication and Alzheimer’s disease at July 20 lunch and learn
Do you have a loved one with Alzheimer’s disease or dementia? Are you looking for ways to communicate when words are lost? Read MoreJul 13, 2016